DRB triphosphate inhibits activity of isolated RNA polymerase B, and, to a lesser extent, that of polymerase A. The same holds true for transcription in isolated nuclei. It does not act as an initiation inhibitor. In all cases, high concentrations of DRB triphosphate are required. Cells do not phosphorylate DRB to a measurable extent, hn RNA resistant to DRB is initiated with both ATP and GTP in the presence of the drug. These experiments render the hypothesis unlikely that DRB triphosphate in the cell specifically interferes with the initiation reaction of polymerase B.
INTRODUCTION
The nucleoside analogue 5,6-dichloro-l-B-D-ribofuranosylbenzimidazole (DRB) has recently received much attention as an inhibitor of RNA synthesis in eukaryotic cells (1) . It inhibits hn RNA synthesis partially, whereas m-RNA production is suppressed by more than 95 % (2-4). Only at higher concentrations are r-RNA synthesis and processing affected (5) .
On the basis of pulse-chase experiments, it has been concluded that the drug acts as an inhibitor of hn RNA chain initiation (6-7). We recently demonstrated that pretreatment of Ehrlich ascites cell cultures with the drug results in an elimination of a specific fraction of RNA polymerase B active in the isolated nuclei (8) . Polymerase A did not respond to this drug treatment.
The action of DRB on cell metabolism has recently been extensively reviewed by Sehgal and Tamm (9) . In a comment on the effect on RNA metabolism, the authors pose the question for future work: "Is DRB itself the active component or is it metabolized by the cell to an active derivative such as triphosphate?". The present paper deals with this question. No significant difference in RNA polymerase activity was observed when the inhibitor was added before or after the initiation reaction. The validitv of this experimental approach was verified by using aurintricarboxylie acid (ATA) as inhibitor (Fig. 2b) Effect of DRB triphosphate on RNA synthesis in isolated nuclei. Fig. 4 shows that polymerase B in nuclei isolated by lysis of cells with saponin (8) was more sensitive to DRB triphosphate than polymerase A, as was found with the isolated enzymes. The differences of the dose-effect curves may be explained by the higher substrate concentrations used in the assays of the isolated nuclei.
Effect of DRB triphosphates on isolated polvmerases. The activity of
Additional experiments (data not shown) revealed that neither DRB nor DRB monophosphate have any effect on transcription in either the isolated nuclei or the purified polymerase systems (26).
Is DRB phosphorylated by the cells? The use of DRB monophosphate and DRB triphosphate as reference substances in chromatographic experiments allowed us to study whether DRB is phosphorylated in vivo. Cells were incubated in the presence of DRB with labeled phosphate. Acid soluble material was extracted and subjected to two-dimensional thin-layer chromatography. As controls, extracts were prepared from cells labeled in the absence of DRB or in Hj pppGp (5000 cpra) as markers. P 2 PJ pppAp and I PJpppGp were purified from the digests using DEAE-Sephadex A25 capillary columns ( 8 , 18) and rechromatographed on a second capillary column : a) pppAp and b) pppGp from control c e l l s ; c) pppAp and d) pppGp from DRB-treated c e l l s . The pppAp preparations contain a shoulder of pppGp.
DISCUSSION
The mechanism by which ORB interferes with the synthesis of hn RNA is still unknown. Since the drug is a nucleoside analogue, it seemed likely that DRB is phosphorylated upon entry into the cell and exerts its effect at the triphosphate level (1, 9) . The specific effect on RNA polymerase B could be explained by a higher affinity of this enzyme for DRB triphosphate as compared to polymerase A and C. A preferential inhibition of the initiation reaction could be due to the more stringent requirements of this step as compared to elongation (23, 24) . Moreover, the finding that only a fraction of hn RNA is sensitive to the drug could be explained by a heterogeneity of the initiation event; possibly only GTP or ATP initiations are inhibited.
Our initial findings that DRB triphosphate inhibits the transcriptional activity of isolated RNA polymerase and of isolated nuclei are consistent with this hypothesis (Figs. 1 and 4) . These experiments also revealed the preferential inhibition of polymerase B in these systems in analogy to the effect of DRB in vivo. The fact that the inhibitory action is more pronounced in the presence of poly d(AT) than of poly d(GC) might indicate that DRB triphosphate is an analogue of ATP rather than of GTP.
However, the further investigations cast doubt on the simple explanation of the DRB effect outlined above. The results described in Fig. 2 and Fig. 3 clearly indicate that there is no preferential inhibition of the initiation reaction. They are more compatible with a reduction of the rate of elongation by DRB triphosphate.
The high concentration of DRB triphosphate required indicates a rather low affinity of the inhibitor for the polymerase. If inhibition were at the triphosphate level then one might expect that a measurable amount of DRB would be phosphorylated j_n vivo. However, DRB does not accumulate in the cells to a measurable extent and remains at an intracellular concentration far below that of ATP. We therefore conclude that the inhibition of RNA synthesis jji vivo does not result from the effects of DRB triphosphate found in the in vitro systems. Consistent with this argument is the rapid reversibility of the in vivo effect of DRB (7); nucleoside triphosphates are normally not released from the cells.
The observation that both 5'pppG and 5'pppA ends are found labeled in the hn RNA resistant to DRB (Fig. 6) shows that normal RNA chain initiations with both purine nucleotides can occur in the presence of the drug. Thus the fact that DRB affects only a fraction of hn RNA synthesis cannot be explained by an interference with either A or G initiations.
Recent experiments on transcription of the adenovirus genome support our conclusion that the effect of DRB cannot be on the RNA chain initiation reaction. It was found that the point of DRB action is located a few hundred nucieotides downstream from the 5' end of the primary transcript ( with the technical assistance of Karin Herrmann and Ursula Rossler
